Related references
Note: Only part of the references are listed.Prenatal Poly I:C Challenge Affects Behaviors and Neurotransmission via Elevated Neuroinflammation Responses in Female Juvenile Rats
Yueqing Su et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
Sex differences in the effect of maternal immune activation on cognitive and psychosis-like behaviour in Long Evans rats
Andrea Gogos et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2020)
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
Radhika Chadha et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders
Yueqing Su et al.
PHARMACOLOGICAL RESEARCH (2020)
Maternal Immune Activation by Poly I:C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia
Faraj L. Haddad et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects
Katie N. Murray et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain
Bo Pan et al.
PSYCHOPHARMACOLOGY (2019)
Brain changes in a maternal immune activation model of neurodevelopmental brain disorders
Lara Bergdolt et al.
PROGRESS IN NEUROBIOLOGY (2019)
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia
Ashleigh L. Osborne et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses
Satoru Matsuda et al.
DISEASES (2019)
Poly (I:C) Exposure in Early Life Alters Methylation of DNA and Acetylation of Histone at Synaptic Plasticity Gene Promoter in Developing Rat Brain Leading to Memory Impairment
Meghraj Singh Baghel et al.
ANNALS OF NEUROSCIENCES (2019)
Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and -aminobutyric acid A receptors in nucleus accumbens of juvenile rats
Bo Pan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Chronic lurasidone treatment normalizes GABAergic marker alterations in the dorsal hippocampus of mice exposed to prenatal immune activation
A. Luoni et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies
Jeroen C. de Jonge et al.
FRONTIERS IN PSYCHIATRY (2017)
Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats
Bo Pan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats
Bo Pan et al.
SCIENTIFIC REPORTS (2016)
Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats
Bo Pan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System
Michael De Santis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Behavioral Effects of the Benzodiazepine-Positive Allosteric Modulator SH-053-2'F-S-CH3 in an Immune-Mediated Neurodevelopmental Disruption Model
Juliet Richetto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
The Poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery
Sonali Reisinger et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens
Su Xu et al.
SCHIZOPHRENIA RESEARCH (2015)
GAD67 Deficiency in Parvalbumin Interneurons Produces Deficits in Inhibitory Transmission and Network Disinhibition in Mouse Prefrontal Cortex
Matthew S. Lazarus et al.
CEREBRAL CORTEX (2015)
Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats
Bo Pan et al.
PLOS ONE (2015)
Altered Cortical Expression of GABA-Related Genes in Schizophrenia: Illness Progression vs Developmental Disturbance
Gil D. Hoftman et al.
SCHIZOPHRENIA BULLETIN (2015)
Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: Focus on children, adolescents and prescriber specialty
Emily A. Karanges et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems
Urs Meyer
BIOLOGICAL PSYCHIATRY (2014)
Sex differences in animal models of psychiatric disorders
N. Kokras et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Risperidone for non-psychotic disorders in paediatric patients: which child is to benefit?
Pieter J. Hoekstra
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2014)
The use of antipsychotics in preschoolers: A veto or a sensible last option?
Jessica Memarzia et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Prenatal Immune Activation Induces Maturation-Dependent Alterations in the Prefrontal GABAergic Transcriptome
Juliet Richetto et al.
SCHIZOPHRENIA BULLETIN (2014)
National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians
Mark Olfson et al.
JAMA PSYCHIATRY (2014)
Epigenetic changes at gene promoters in response to immune activation in utero
Bin Tang et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease
Roman Willi et al.
NEUROPHARMACOLOGY (2013)
Lithium and GSK3-β Promoter Gene Variants Influence White Matter Microstructure in Bipolar Disorder
Francesco Benedetti et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies
G. M. Khandaker et al.
PSYCHOLOGICAL MEDICINE (2013)
Neuregulin-1 signalling and antipsychotic treatment Potential therapeutic targets in a schizophrenia candidate signalling pathway
Chao Deng et al.
PSYCHOPHARMACOLOGY (2013)
Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents
Silvio Caccia
PEDIATRIC DRUGS (2013)
The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3
Laurie P. Sutton et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Efficacy of Risperidone in Managing Maladaptive Behaviors for Children With Autistic Spectrum Disorder: A Meta-Analysis
Akanksha Sharma et al.
JOURNAL OF PEDIATRIC HEALTH CARE (2012)
Antipsychotics for Children and Young Adults: A Comparative Effectiveness Review
Jennifer C. Seida et al.
PEDIATRICS (2012)
Genetic overlap between schizophrenia and bipolar disorder: A study with AKT1 gene variants and clinical phenotypes
Felicien Karege et al.
SCHIZOPHRENIA RESEARCH (2012)
AKT/GSK3 signaling pathway and schizophrenia
Effat S. Emamian
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
David Fraguas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
DYNAMIC REGULATION OF MIDBRAIN DOPAMINE NEURON ACTIVITY: INTRINSIC, SYNAPTIC, AND PLASTICITY MECHANISMS
H. Morikawa et al.
NEUROSCIENCE (2011)
Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
John A. Allen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
Zachary Freyberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Alan S. Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity
F. Benedetti et al.
GENES BRAIN AND BEHAVIOR (2010)
Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency
Byron K. Y. Bitanihirwe et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Trends in Antipsychotic Drug Use by Very Young, Privately Insured Children
Mark Olfson et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2010)
Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia
Byron K. Y. Bitanihirwe et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Jean-Martin Beaulieu et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring
Stephen L. Buka et al.
BIOLOGICAL PSYCHIATRY (2008)
Physiological roles of PKB/Akt isoforms in development and disease
B. Dummler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
The effects of antipsychotics on β-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats
H Alimohamad et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs
TD Gould et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
H Alimohamad et al.
BIOLOGICAL PSYCHIATRY (2005)
Share Paper
